Trialize

Based in Switzerland, Trialize provides an AI-based and robotic process automation platform to help optimize clinical trials and manage trial-related functions. Trialize’s decentralized trial platform assists clinical trial operators with key aspects of trials, including recruitment, engagement, prescreening, monitoring, regulatory and compliance, data management, and collaboration. The platform is additionally customizable, allowing trial operators to select customized processes depending on their individual requirements.

While the company claims its platform can speed up trial timelines, improve data quality, and enhance patient engagement for pharmaceutical developers, the platform is also made available to contract research organizations, academic institutions, research centers, healthcare providers and clinics, regulatory agencies, ethics committees, and patients and patient advocacy groups.

In April 2024, the company launched an open-source framework called the Trial Data Object Model (TDOM). TDOM was developed to standardize data exchange between clinical systems, focusing on efficient, accurate, and swift data sharing. Core functions of this framework include creating a standard data model tailored for clinical trials, building connectors for integration with current data management systems, and ensuring improved clinical trial efficiency through better data management. The framework was projected to simplify data management, maintain data integrity, and speed up the development of medical treatments due to streamlined research processes.

Key customers and partnerships

Trialize serves a global clientele, including pharmaceutical companies, biotech firms, and clinical research organizations (CROs).